Sales and Marketing

Showing 15 posts of 11524 posts found.

Price cuts bring 14 Cancer Drugs Fund treatments into routine NHS use

March 3, 2017 Medical Communications, Sales and Marketing CDF, NICE

NICE has revealed that it has reached the halfway point in its review of the old Cancer Drugs Fund (CDF) …
cma_logo

CMA accuses Concordia and Actavis of illegal agreement to maintain high prices

March 3, 2017 Medical Communications, Sales and Marketing Actavis UK, CMA, Concordia, competition and markets authority

The Competition and Markets Authority (CMA) has alleged that Concordia and Actavis UK entered into a clandestine agreement to maintain …

Ipsen appoints new Executive Vice President

March 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ipsen

Ipsen has announced the appointment of Benoit Hennion as Executive Vice President and President of Primary Care. Hennion has worked …
shutterstock_128521253

Are we prepared for the ‘real world’?

March 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing opinion, real world data, recruitment

Dr Dilruwan Chaminda Herath, Medical Director for Chiesi Group, discusses whether the lack of impetus to push for recruitment of …

NICE approves first biliary cholangitis drug in 20 years

March 2, 2017 Sales and Marketing Intercept Pharmaceuticals, intercept, liver disease, ocaliva, primary biliary cholangitis

Intercept Pharmaceuticals has announced that Ocaliva (obeticholic acid) has been approved by the National Institute for Health and Care Excellence …
novartis_headquarters

South Korea fines Novartis over kickbacks scandal

March 2, 2017 Medical Communications, Sales and Marketing Kickback, Novartis, south korea

South Korea’s Ministry of Food and Drug Safety has fined Novartis 200 million won ($174,936) over the payment of kickbacks …
scott_smith_252

New COO for Celgene

March 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

Celgene released in a statement that its Chief Operating Officer and President, Jacqualyn “Jackie” Fouse, will retire from her position. …

Graham Dunkley chooses Medica’s Pharma Cartons

March 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medica Packaging

Medica Packaging is pleased to announce that Graham Dunkley, most recently of Multi Packaging Solutions (MPS) has joined Medica as …
jakob-riis

Novo Nordisk’s Head of North America resigns

March 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, appointment

Novo Nordisk has announced the surprising news that its Executive Vice President, Head of North American Operations Jakob Riis has …
keytruda1

NICE knocks back MSD’s Keytruda for lung cancer indication

February 28, 2017 Research and Development, Sales and Marketing MSD, NICE, NSCLC, keytruda

MSD’s immunotherapy drug Keytruda (pembrolizumab) has been knocked back by the National Institute of Health and Care Excellence (NICE) for …

FDA green lights AstraZeneca type-2 diabetes drug

February 28, 2017 Manufacturing and Production, Sales and Marketing AstraZeneca, FDA

AstraZeneca has announced that its type-2 diabetes treatment Qtern (10mg dapagliflozin and 5mg saxagliptin) has received the approval of the …
janssen_latest_logo_on_sign_closer

EMA recommends expanded indication for Janssen multiple myeloma drug

February 27, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Janssen, darzalex

The European Medicines Agency’s Committee for Medicinal Products for Human Use has given its positive opinion for the use of …
c5rxfeiwyaez8kv

Moderna Therapeutics instates MIT Treasurer to Board of Directors

February 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MIT, Moderna, Moderna Therapeutics

Moderna Therapeutics, a clinical stage biotechnology company, has announced the appointment of Israel Ruiz to the company’s Board of Directors. …

Does Trump pose a threat to the FDA’s future?

February 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump

President Trump’s first month in office made headlines across the industry just as it did in the wider media. Promises …
merckincweb1

MSD’s investigational cytomegalovirus treatment shows significant promise in Phase 3 trial

February 27, 2017 Research and Development, Sales and Marketing MSD, cytomegalovirus, letermovir

MSD has lifted the curtain on strong Phase 3 results in the development of its investigational antiviral drug letermovir, showing …
The Gateway to Local Adoption Series

Latest content